We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene Deletions Affect Rapid Diagnostic Tests for Malaria

By LabMedica International staff writers
Posted on 25 Jul 2019
Print article
Image: A Giemsa-stained, thin film blood smear that shows the presence of numerous of ring-form, Plasmodium falciparum trophozoites, with some infected red blood cells (RBCs) harboring multiple organisms (Photo courtesy of Steve Glenn/CDC).
Image: A Giemsa-stained, thin film blood smear that shows the presence of numerous of ring-form, Plasmodium falciparum trophozoites, with some infected red blood cells (RBCs) harboring multiple organisms (Photo courtesy of Steve Glenn/CDC).
Prompt and accurate diagnosis of malaria is crucial for malaria case-management and control and elimination programmes. While malaria diagnosis was historically based on symptoms alone, guidelines state that parasite-based diagnosis of malaria should be confirmed before treatment is given.

Malaria rapid diagnostic tests (mRDT) that target histidine-rich protein 2 (HRP2) are important tools for Plasmodium falciparum diagnosis. Parasites with pfhrp2/3 gene deletions threaten the use of these mRDTs, and have been reported in Africa, Asia, and South America. The absence of both HRP2 and HRP3 renders the parasites undetectable by HRP2-based mRDTs.

Scientists at the London School of Hygiene & Tropical Medicine (London, UK) and their colleagues analyzed P. falciparum parasites identified in human blood samples from three malaria studies in Ghana, Tanzania and Uganda. They analyzed 911 dried blood spots 165 from Ghana, 176 from Tanzania and 570 from Uganda (570). P. falciparum infection was confirmed by 18SrDNA polymerase-chain reaction (PCR), and pfhrp2/3 genes were genotyped.

True pfhrp2/3 gene deletions were confirmed if samples were (1) microscopy positive, (2) 18SrDNA polymerase chain (PCR) positive, (3) positive for merozoite surface protein genes by PCR, or positive by loop-mediated isothermal amplification (LAMP), and (4) quantitative PCR positive with > 5 parasites/µL. To confirm the deletion of pfhrp2 and pfhrp3 genes, PCR of two other single copy genes was performed.

The team reported that among the samples from Ghana, 107/165 (64.9%) were recorded as positive by mRDT and 82/165 (49.7%) by microscopy. In Tanzania, 72/171 (53.8%) samples were recorded as positive by mRDT, while 140/176 (79.6%) were positive by microscopy. Of the 570 Uganda samples, 258/570 (45.3%) were recorded as positive by mRDT, and 203 (35.6%) were positive by microscopy. No pfhrp2/3 deletions were detected in samples from Ghana, but deletions were identified in Tanzania (three pfhrp2; two pfhrp3) and Uganda (seven pfhrp2; two pfhrp3). Of the 10 samples with pfhrp2 deletions, nine tested negative by HRP2-based mRDT.

The authors concluded that the presence of pfhrp2/3 deletions in Tanzania and Uganda, along with reports of pfhrp2/3-deleted parasites in neighboring countries, reinforces the need for systematic surveillance to monitor the reliability of mRDTs in malaria-endemic countries. The study was published on June 28, 2019, in the Journal of Infectious Diseases.

Related Links:
London School of Hygiene & Tropical Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Reagent Reservoirs
Reagent Reservoirs

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.